Tufts Medical Center, Boston, MA.
Temple University, Philadelphia, PA.
Chest. 2021 Nov;160(5):e389-e397. doi: 10.1016/j.chest.2021.06.082. Epub 2021 Jul 30.
This document summarizes the work of the COPD Technical Expert Panel working group. For patients with COPD, the most pressing current coverage barriers identified were onerous diagnostic requirements focused on oxygenation (rather than ventilation) and difficulty obtaining bilevel devices with backup rate capabilities. Because of these difficulties, many patients with COPD were instead sometimes prescribed home mechanical ventilators. Critical evidence supports changes to current policies, including randomized controlled trial evidence suggesting a mortality benefit from bilevel positive airway pressure with backup rate and updated clinical practice guidelines from the American Thoracic Society as well as the European Respiratory Society. To achieve optimal access to noninvasive ventilation for patients with COPD, we make the following key recommendations: (1) removal of the need for overnight oximetry testing; (2) the ability to initiate therapy using bilevel devices with backup rate capability; and (3) increased duration of time to meet adherence criteria (ie, a second 90-day trial period) in those patients actively engaged in their care. Clear guidelines based on medical necessity are also included for patients who require initiation of or switch to a home mechanical ventilator. Adoption of these proposed recommendations would result in the right device, for the right type of patient with COPD, at the right time. Finally, we emphasize the need for adequate clinical support during initiation and maintenance of home noninvasive ventilation in such patients.
本文件总结了 COPD 技术专家小组工作组的工作。对于 COPD 患者,目前发现最紧迫的覆盖障碍是繁琐的诊断要求,侧重于氧合(而非通气),以及难以获得具有后备频率功能的双水平设备。由于这些困难,许多 COPD 患者有时被处方家用呼吸机。关键证据支持对现行政策进行修改,包括随机对照试验证据表明,双水平正压通气加后备频率具有降低死亡率的益处,以及美国胸科学会和欧洲呼吸学会更新的临床实践指南。为了使 COPD 患者能够获得最佳的无创通气机会,我们提出以下关键建议:(1)取消对夜间血氧饱和度测试的需求;(2)能够使用具有后备频率功能的双水平设备开始治疗;(3)在积极参与护理的患者中,增加满足依从性标准的时间(即第二次 90 天试验期)。还为需要开始或转换为家用呼吸机的患者提供了基于医疗必要性的明确指南。采用这些建议将为合适类型的 COPD 患者在合适的时间提供合适的设备。最后,我们强调在这些患者开始和维持家用无创通气时需要提供足够的临床支持。